Diamond Logo
Diamond Logo
Sysmex CA660
Sysmex CA660

Sysmex CA660

Item# 0-SX-CA660


The CA-660 Coagulation analyzer, by Sysmex Corporation

Package Size: EA




Smartlyte Plus

The CA-660 Coagulation analyzer, by Sysmex Corporation. Coagulation analysis detects abnormalities in the components required to complete normal blood clotting. Analysis is divided into two elements; the measurement of clot timing and if the timing is abnormal, a deeper analysis to determine which factors affecting normal coagulation are deficient. Clotting disorders are either classified as Hypocoagulability, a disorder of impaired or slowed coagulation and Hypercoagulability, a disorder of unnaturally fast clotting time or manner. Hypocoagulability can result in hemorrhage or other acquired coagulation disorders such as Hemophilia while Hypercoagulability can cause unnatural clots in arteries and other vessels which could result in severe organ damage or possibly death. A balance normally exists between the factors that stimulate formation of thrombin and forces acting to delay thrombin formation. This balance maintains circulating blood as a fluid. When injury occurs or blood is removed from a blood vessel, this balance is upset and coagulation begins. Coagulation may occur unexpectedly and internally. Symptoms for coagulation disorders are spontaneous bruising, prolonged bleeding, abnormal nosebleeds, heavy menstrual flow or gastrointestinal bleeding.

ISO
ISO
Facebook
Instagram
Contact Us

Corporate Headquarters (USA)
Diamond Diagnostics Inc.
333 Fiske Street
Holliston, MA 01746-2048
Tel: +1 508.429.0450

Distribution Center (EU)
Diamond Diagnostics Kft.
1044 Budapest, Hungary
Óradna Street 6
Tel: +36 (1) 787 2222

Quality

ISO 9001:2015 (US)
ISO 9001:2015 (EU)
ISO 13485:2016 (US)
ISO 13485:2016 (EU)

Diamond Diagnostics Inc. is registered with the United States Food and Drug Administration as an Initial Importer Manufacturer and Contract Manufacturer. Establishment registration and device listing can be found under ID: 3003030793.

Diamond has been registered with the Food and Drug Administration since 2001 and regulated by its cGMP system requirements.

All products manufactured by Diamond carry the necessary FDA clearance and comply to the European Union IVD Directive. Every department and function in our company is standardized, controlled and routinely audited.

FDA logo

The names and logos of manufacturers, their instruments, and their products referred to herein may be protected by trademark or other law, and are used herein solely for purpose of reference. Products are available for international distribution only unless otherwise indicated. Diamond Diagnostics expressly disclaims any affiliation with products it does not manufacture, as well as sponsorship by other manufacturers. For current regulatory status on products within this website, please contact your sales representative. Prices and Information shown are for reference only and may change without notice. SmartLyte®, ProLyte®, CareLyte®, and Down-To-Frame® Refurbishing are Registered Trademarks of Diamond Diagnostics®.

©2021 Diamond Diagnostics®All Rights Reserved.